These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
290 related items for PubMed ID: 3015558
1. Evidence for tight coupling of receptor occupancy by thyrotropin-releasing hormone to phospholipase C-mediated phosphoinositide hydrolysis in rat pituitary cells: use of chlordiazepoxide as a competitive antagonist. Gershengorn MC, Paul ME. Endocrinology; 1986 Aug; 119(2):833-9. PubMed ID: 3015558 [Abstract] [Full Text] [Related]
2. A constitutively active mutant thyrotropin-releasing hormone receptor is chronically down-regulated in pituitary cells: evidence using chlordiazepoxide as a negative antagonist. Heinflink M, Nussenzveig DR, Grimberg H, Lupu-Meiri M, Oron Y, Gershengorn MC. Mol Endocrinol; 1995 Nov; 9(11):1455-60. PubMed ID: 8584022 [Abstract] [Full Text] [Related]
3. Effects of thyrotropin-releasing hormone on phosphoinositides and cytoplasmic free calcium in thyrotropic pituitary cells. Brenner-Gati L, Gershengorn MC. Endocrinology; 1986 Jan; 118(1):163-9. PubMed ID: 3000732 [Abstract] [Full Text] [Related]
4. Thyrotropin-releasing hormone receptor occupancy determines the fraction of the responsive pool of inositol lipids hydrolysed in rat pituitary tumour cells. Cubitt AB, Geras-Raaka E, Gershengorn MC. Biochem J; 1990 Oct 15; 271(2):331-6. PubMed ID: 2173558 [Abstract] [Full Text] [Related]
5. Thyrotropin-releasing hormone stimulation of phosphoinositide hydrolysis desensitizes. Evidence against mediation by protein kinase C or calcium. Perlman JH, Gershengorn MC. Endocrinology; 1991 Nov 15; 129(5):2679-86. PubMed ID: 1657582 [Abstract] [Full Text] [Related]
6. Chlordiazepoxide is a competitive thyrotropin-releasing hormone receptor antagonist in GH3 pituitary tumour cells. Drummond AH. Biochem Biophys Res Commun; 1985 Feb 28; 127(1):63-70. PubMed ID: 2983718 [Abstract] [Full Text] [Related]
7. U-73122, an aminosteroid phospholipase C antagonist, noncompetitively inhibits thyrotropin-releasing hormone effects in GH3 rat pituitary cells. Smallridge RC, Kiang JG, Gist ID, Fein HG, Galloway RJ. Endocrinology; 1992 Oct 28; 131(4):1883-8. PubMed ID: 1396332 [Abstract] [Full Text] [Related]
8. Polyphosphoinositide hydrolysis by phospholipase C is accelerated by thyrotropin releasing hormone (TRH) in clonal rat pituitary cells (GH3 cells). Schlegel W, Roduit C, Zahnd GR. FEBS Lett; 1984 Mar 12; 168(1):54-60. PubMed ID: 6323219 [Abstract] [Full Text] [Related]
13. Phosphatidylinositol 4,5-bisphosphate turnover is transient while phosphatidylinositol turnover is persistent in thyrotropin-releasing hormone-stimulated rat pituitary cells. Imai A, Gershengorn MC. Proc Natl Acad Sci U S A; 1986 Nov 05; 83(22):8540-4. PubMed ID: 3022295 [Abstract] [Full Text] [Related]
14. Thyrotropin-releasing hormone stimulates inositol phosphate production in normal anterior pituitary cells and GH3 tumour cells in the presence of lithium. Baird JG, Dobson PR, Wojcikiewicz RJ, Brown BL. Biosci Rep; 1983 Dec 05; 3(12):1091-9. PubMed ID: 6421341 [Abstract] [Full Text] [Related]
15. The G alpha q and G alpha 11 proteins couple the thyrotropin-releasing hormone receptor to phospholipase C in GH3 rat pituitary cells. Aragay AM, Katz A, Simon MI. J Biol Chem; 1992 Dec 15; 267(35):24983-8. PubMed ID: 1334076 [Abstract] [Full Text] [Related]
16. Thyroliberin stimulates rapid hydrolysis of phosphatidylinositol 4,5-bisphosphate by a phosphodiesterase in rat mammotropic pituitary cells. Evidence for an early Ca2+-independent action. Rebecchi MJ, Gershengorn MC. Biochem J; 1983 Nov 15; 216(2):287-94. PubMed ID: 6318733 [Abstract] [Full Text] [Related]